Company Quick10K Filing
CIM Commercial Trust
10-Q 2020-09-30 Filed 2020-11-09
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-16
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-18
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-12
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-16
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-15
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-16
10-Q 2014-09-30 Filed 2014-11-10
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-10
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-09
10-K 2012-12-31 Filed 2013-03-18
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-15
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-16
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-16
8-K 2021-02-11 Officers, Other Events
8-K 2020-12-24 Other Events
8-K 2020-12-22 Other Events
8-K 2020-11-03
8-K 2020-09-02
8-K 2020-08-10
8-K 2020-07-13
8-K 2020-05-26
8-K 2020-05-07
8-K 2020-04-09
8-K 2020-03-16
8-K 2020-01-28
8-K 2019-12-20
8-K 2019-11-08
8-K 2019-09-03
8-K 2019-08-12
8-K 2019-08-08
8-K 2019-07-30
8-K 2019-06-18
8-K 2019-06-04
8-K 2019-05-24
8-K 2019-05-13
8-K 2019-05-01
8-K 2019-03-29
8-K 2019-03-18
8-K 2019-03-01
8-K 2019-01-17
8-K 2018-12-17
8-K 2018-11-13
8-K 2018-10-05
8-K 2018-08-09
8-K 2018-05-10
8-K 2018-05-03
8-K 2018-03-28
8-K 2018-01-30

CIM Commercial Trust Financials

CMCT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE) 450 5.1 1% 3,541 3,244 0 0 39 78 398
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU) 0% 1,497 0 0 0 0 -308
SQL Technologies (SQFL) 18% 1.5 0% 7 30 9 2 0 2 3
2-Track Global (TTG)
GB Sciences (GBLX) 23 -23% -1.8 -56% 30 16 4 -1 -17 -13 23
Nemaura Medical (NMRD) 158 -32.0 -182% 3 3 0 0 -5 -5 156
Monroe Bank and Trust (MBTF) 232 -6.6 1% 1,327 1,191 0 0 10 16 -107
Solis Tek (SLTK) 44 51% -25.8 -163% 1 7 2 1 -2 -2 44
Cumulus Media (CMLS) -94.7 -0% 0 0 0 -11 1,004
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash797314186138242031182023331259382134144404129253129701141197731138426
Accounts Receivable
Inventory
PP&E1,6751,7121,7011,7161,7041,7001,7021,6921,6651,6251,6151,6071,5051,1419419581,0851,0761,0671,041668504506
Assets2532612512472552542482562492502532,0512,0732,0792,0952,1062,0912,0932,0982,1062,1512,0562,0232,1661,6381,5911,3361,3581,3881,3921,3421,1871,197660
Accounts Payable
Long-Term Debt96104969410110197106102105109566598621609642648665664663947974972944851784634644671668595170167232
Liabilities1031121041011111121081171101121176386746977357647657898018111,0871,0781,0551,019984866682699722725689243197262
Stockholders' Equity1491481471451431421381381381371351,4111,3961,3791,3591,3411,3251,3031,2961,2941,0639779661,143646711626624624623616909966360
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue444445454546471686567676668666564656761555348524850473729
Cost of Revenue
Gross Profit
R&D
SG&A11001011111143-1322222222211321221
Tax-0-00-00000000000-00000010011000000
Net Income111-0-00-2120-011941355112719-219491722212-1-1292533
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-20-3-442111-212251610271822726172148-5-1818191315127
Cash Investing-284-421-223-6-1-37-1-20-5-493-28-256913291347197134-115-5-6642107172
Cash Financing6-10-46-3-58-523-48-412-21-6-14-13-39-21-5-45-627-69-2411230-2-423-44-539